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Background: Thyroglobulin (Tg) is a large glycoprotein that is intimately involved in the biosynthesis of thyroxine
and triiodothyronine. At least 38 mutations have been described in the Tg gene that are associated with varying
degrees of hypothyroidism. We studied the Tg gene in four related subjects with congenital hypothyroidism.
Summary: We found a novel compound heterozygous constellation (IVS30 + 1G>T=A2215D) in a brother and
sister and one previously described related mutation (IVS30+1G>T) in their two sibling second degree cousins.
The brother with the IVS30 + 1G>T=A2215D mutation and the two siblings with the IVS30+1G>T mutation had
fetal or neonatal goiter and all had hypothyroidism.
Conclusions: This study further confirms the association of the IVS30+G>T mutation of the Tg gene with hy-
pothyroidism. Computer analysis predicts that the A2215D mutation, first reported here, should cause structural
instability of Tg but when present as a compound heterozygous mutation with IVS30+G>T=A its effect is unclear
but is likely to be influenced by iodine intake.
Introduction
Thyroglobulin (Tg) is a large glycoprotein andfunctions as a matrix for thyroid hormone synthesis. The
coding gene is located on chromosome 8q24 and contains an
8.5-kb coding sequence divided into 48 exons (1). Thirty-
eight inactivating mutations have been identified in the human
Tg gene and at least 12 alternative splice products have been
detected in wild-type Tg mRNA (2). We herein describe four
children with congenital hypothyroidism (CH) due to Tg de-
fective synthesis in an inbred family from northeastern Brazil
and a new Tg compound heterozygous constellation.
Patient IV-2 and IV-3. The two affected siblings from this
kindred were born to non-consanguineous parents (Fig. 1).
Patient IV-3 had with neonatal goiter by history. At the age
of 11.7 years, he presented with stunted growth (height age of 7
years), delayed bone age (9 years), and thyroid enlargement
(21.3 mL) by ultrasound (US). He was started on L-thyroxine
5 mg=kg and 3 months later serum thyroxine (T4) and triiodo-
thyronine (T3) were normal but recombinant human thyro-
tropin (rhTSH)-stimulated Tg was low (Table 1). L-thyroxine
treatment was continued and the patient had normal somatic
development but mild mental retardation (IQ¼ 65). Patient
IV-2, the second-born daughter had thyroid enlargement,
elevated serum TSH, and normal serum T3 and T4 at 2 months
(Table 1). She was started on L-thyroxine 10mg=kg per day
and at age of 11 years, she had normal thyroid volume,
normal thyroid function tests, unremarkable somatic deve-
lopment, and no mental retardation (IQ¼ 96).
Patients V-1 and V-2. They are second-degree cousins of
the first two patients and were born to consanguineous
parents (3) (Fig. 1). Patient V-1 was the first-born son. By
history he had a neonatal goiter and was started on
L-thyroxine during his first year of life with visible reduction
in goiter. At age 6 while on L-thyroxine, TSH, T3, and T4 were
normal but rhTSH stimulated Tg was low (Table 1). Bone age
was delayed (32 months) and he had mental retardation
(IQ¼ 63). The history of patient V-2 revealed that US of her
mother at 26 weeks of gestation identified a large fetal goiter
(volume 12.3 mL). At 29 weeks, fetal hypothyroidism was
confirmed by cordocentesis (TSH 61.3 mU=L) (Table 1). Four
weeks after a single intra-amniotic injection of L-thyroxine
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400 mg, marked reduction in the goiter was noted on US
(4.8 mL). Cord serum TSH, total T4, and free T4 were normal
at birth, thyroid volume was 1.8 mL, and serum Tg level was
at the lower limit of detection (Table 1). At 5 years somatic
and mental development were normal (IQ¼ 96).
In all patients, absence of synthesis and secretion of Tg
was confirmed by lack of serum Tg elevation 24 and 48 hours
after 0.1 mg intramuscular injection of rhTSH (Table 1) (4). At
the time of this study all the patients had excessive iodine
intake (urinary iodine concentration 335–492 mg=L, normal
range 100–299 mg=L) (5). In siblings V-1 and V-2 direct se-
quencing revealed the homozygous mutation IVS30þ1G>T
(6,7). Their parents were heterozygous for this mutation (Fig. 1).
In patients IV-2 and IV-3, we identified a novel compound
heterozygous constellation IVS30þ1G>T=A2215D. The het-
erozygous A2215D mutation (8) was also found in these pa-
tients’ mother, and the heterozygous IVS30þ1G>T in the
patients’ father (Fig. 1).
This intronic mutation is caused by guanine to thymine
transversion at position þ1 in the donor splice site of intron
30, promoting an aberrant splicing and loss of the entire exon
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FIG. 1. Family pedigree. Siblings V-1 and V-2 had the homozygous mutation IVS30þ 1G>T and patients IV-2 and IV-3 had
the compound heterozygous constellation IVS30þ 1G>T=A2215D. Note: Genomic DNA was isolated from peripheral blood
DNA by the sodium dodecyl sulfate–proteinase K method. The complete coding sequence of the Tg gene, including splicing
signals and flanking intronic regions of each intron, was amplified by polymerase chain reaction (PCR) (13). DNA sequencing
from each amplified fragment was performed with DYEnamic ET dye Terminator kit (Megabace, Amersham Biosciences, GE,
Piscataway, NJ). The sequences were compared with the human Tg gene sequence (GenBank accession number NY_008046).










(pmol=L) Basal Stimulated rhTSH
IV-2 23 3.1 61.8 — 0.7 0.6
IV-3b 0.83 3.2 121 — 0.8 0.5
V-1b 0.9 2.8 154.4 24.5 <0.1 <0.1
V-2c 61.3 0.5 38.6 2.6 1.3 —
V-2d 41.6 2.0 135 11.5 <0.1 <0.1
Reference 0.5–4.0 1.2–3.1 51–155 11–25 0.5–15.0 —e
aTSH, thyrotropin; T3, triiodothyronine; T4, thyroxine; Tg, thyroglobulin; rhTSH, recombinant human thyrotropin.
bDuring treatment with L-thyroxine.
cCordocentesis at 29 weeks’ gestation.
dCordocentesis at birth (cord blood).
eStimulation with rhTSH increases serum Tg levels 4–6 fold from baseline levels.
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exon does not affect the reading frame of the mRNA and
potentially codifies a shortened polypeptide. The deletion is
localized in the Tg type III repeat domain, causing the loss
of 1- putative N-linked glycosylation site (2). The loss of 46
amino acids can modify the tertiary=quaternary structure of
the protein which is then retained inside the endoplasmic
reticulum (ER), reducing the export of the protein to the
colloid (9). This mechanism is known as the quality control of
the ER, and is mediated by molecular chaperones (9). In
patient V-2, fetal goiter and severe fetal hypothyroidism
(Table 1) are clearly the consequence of biosynthetic defects
in fetal thyroid hormonogenesis. Other causes of fetal goiter,
such as deficiency or excess of iodine, exposure to goitro-
gens, ingestion of medications that affect the fetal thyroid
gland, and maternal thyroid autoimmune disease were ex-
cluded in this patient (10). Consequently, the IVS30þ1G
>T Tg mutation is certainly the main etiological factor for the
clinical findings of the patient. In the eldest sibling (V-1) this
mutation also led to a severe clinical condition with stunted
growth and mental retardation despite L-thyroxine replace-
ment during the first year of life. The early intra-utero and
uninterrupted L-thyroxine therapy after birth of his sister
allowed a normal somatic development and absence of neu-
rological sequelae.
The mutation A2215D is caused by cytosine to adenine
nucleotide transition at position 6701 in exon 38 (6701C>A).
This alteration changed alanine to aspartic acid in position
2215 of the protein (A2215D) localized in the AChE homol-
ogy domain of the Tg (8). Alignment analysis revealed that
the wild-type alanine residue at position 2215 is strictly
conserved in all Tg and AChE species analyzed (8). Com-
puter analysis showed that the A2215D mutation can cause
the following changes on the protein structure: a) reduced
stretch of the helix structure, b) reduced stretch of the b-sheet
structure, c) extension of the helix, d) extension of the b-sheet,
and e) introduction of a b-sheet (Protein Structure Prediction-
http:==bioinf.cs.ucl.ac.uk=psipred). Consequently, this muta-
tion may cause structural instability, impairing Tg export to the
colloid. Park and Arvan (11) showed in an animal model that
the AChE-like region of Tg functions as a dimerization do-
main, facilitating efficient intracellular transport of the much
larger Tg, via a secretory pathway. Congenital hypothyroid-
ism in cog=cog mice and rdw rats is caused by a missense
mutation in the AChE-like domain of the Tg molecule. Both
mutated Tg proteins exhibit a severe defect in the exit from the
ER, causing a thyroidal ER storage disease (12).
Patients IV-2 and IV-3 had CH secondary to the com-
pound heterozygous Tg mutation (IVS30þ1G>T=A2215D).
Elevated nutritional iodine intake may partially induce syn-
thesis of thyroid hormones in the mutant Tg protein (1). Uri-
nary iodine excretion in the affected patients was elevated,
and the local population is exposed to a relatively high nu-
tritional iodine environment through iodized salt and daily
use of fish and seafood. Our hypothesis is that these patients
probably synthesize low amounts of thyroid hormone within
the frame of a mutant A2215D Tg, enough for the require-
ment during the first months of postnatal life. This was
clearly observed in the second-born girl (IV-2) who developed
normally and had normal thyroid hormone levels at the age
of 2 months. She was then treated with L-thyroxine and had
normal IQ. Her brother, however, with the same Tg gene
mutations and living in similar environmental conditions, had
a less successful development and presented with some de-
gree of mental retardation due to the delay in CH diagnosis.
In conclusion, we identified a novel compound heterozy-
gous constellation (IVS30þ1G>T=A2215D) in two siblings
and one previously described mutation (IVS30þ1G>T) in
two other siblings that caused defective Tg synthesis and
consequent severe CH. The mutation IVS30þ1G>T, that
leads to an impaired Tg synthesis, affects the thyroid gland
in utero, causing a large fetal goiter. The degree of mutant
(A2215D) Tg that is able to escape the quality control of the
cell along with constant high iodine nutrition will eventually
determine the final phenotypic appearance.
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